Skip to main content

Idorsia — Deal History & Benchmarks

Total Deals
2
Across 2 therapeutic areas
Total Deal Value
$680M
Cumulative transaction value
Most Active Year
2020
1 deal closed
Primary TA
Hematology
50% of deal activity

Market Analysis

Idorsia has been involved in 2 transactions totaling $680M across Hematology, Cardiovascular. As a licensor (out-licensor), they have demonstrated a collaborative partnership model.

PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Customize these benchmarks for your asset

Adjust phase, modality, competitive position, and 10+ other parameters.

Open Calculator

Frequently Asked Questions

How many deals has Idorsia done?
Idorsia has completed 2 verified transactions tracked in our database, spanning from 2020 to 2024. These deals have a combined value of $680M.
PRO

Full Benchmark Analysis

Complete deal term ranges, comparable transactions, and negotiation insights.

We'll email you the full benchmark data for this page. No spam, unsubscribe anytime.

or
Unlock Everything — $299/mo Pro

7-day money-back guarantee · Cancel anytime

Ready to Calculate Your Deal Terms?

Get instant, customized benchmarks based on real market data from 600+ biopharma licensing deals.

Start Calculating